Arch Therapeutics, Inc. (ARTH) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2013

SEC Filings

Arch Therapeutics, Inc.

CIK: 1537561 Ticker: ARTH
Document And Entity Information (USD $)
12 Months Ended
Sep. 30, 2013
Dec. 26, 2013
Document Information [Line Items]    
Document Type 10-K  
Amendment Flag false  
Document Period End Date Sep. 30, 2013  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus FY  
Trading Symbol ARTH  
Entity Common Stock, Shares Outstanding   60,145,237
Entity Registrant Name Arch Therapeutics, Inc.  
Entity Central Index Key 0001537561  
Current Fiscal Year End Date --09-30  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Public Float $ 1,979,600  

View differences made from one year to another to evaluate Arch Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Arch Therapeutics, Inc..


Assess how Arch Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Arch Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statement Of Cash Flows
Consolidated Statements Of Operations
Statements Of Changes In Stockholders' Equity (deficit)
Annual License Maintenance Fee Commitments (detail)
Coldstream Financing
Coldstream Financing - Additional Information (detail)
Commitments And Contingencies
Commitments And Contingencies (tables)
Commitments And Contingencies - Additional Information (detail)
Convertible Notes Payable
Convertible Notes Payable - Additional Information (detail)
Description Of Business
Description Of Business - Additional Information (detail)
Income Taxes
Income Taxes (detail)
Income Taxes (tables)
Income Taxes - Additional Information (detail)
Merger - Additional Information (detail)
Note Payable
Note Payable - Additional Information (detail)
Property And Equipment
Property And Equipment (detail)
Property And Equipment (tables)
Property And Equipment - Additional Information (detail)
Related Party Transactions
Related Party Transactions - Additional Information (detail)
Schedule Of Future Minimum Lease Payments Due (detail)
Stock Compensation Restricted Stock Award Activity (detail)
Stock Compensation Stock Option Activity (detail)
Stock-based Compensation
Stock-based Compensation (tables)
Stock-based Compensation - Additional Information (detail)
Stockholders' Equity
Stockholders' Equity - Additional Information (detail)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (policies)
Warrants - Additional Information (detail)
Weighted Average Restricted Stock Award (detail)

Material Contracts, Statements, Certifications & more

Arch Therapeutics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ARTH
CIK: 1537561
Form Type: 10-K Annual Report
Accession Number: 0001144204-13-069281
Submitted to the SEC: Fri Dec 27 2013 5:26:19 PM EST
Accepted by the SEC: Fri Dec 27 2013
Period: Monday, September 30, 2013
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: